AstraZeneca plc (AZN) Ordinary US$0.25
Share news, reports & tips
8 June 2021 13:54
(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.
7 June 2021 12:58
(Sharecast News) - Sainsbury's: Jefferies downgrades to hold with a target price of 280p.
7 June 2021 09:38
(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.
7 June 2021 07:38
(Sharecast News) - AstraZeneca said on Monday that final results from the head-to-head 'ELEVATE-RR' phase 3 trial of 'Calquence', or acalabrutinib, demonstrated non-inferior...
6 June 2021 12:20
(Sharecast News) - The decision to reopen on June 21 has been made "more difficult" by the Indian variant's spread to the most dominant variant in the UK, the Health Secretary has said. Matt...
4 June 2021 08:33
(Sharecast News) - Pharmaceutical group AstraZeneca has appointed Aradhana Sarin as chief financial officer on Friday, succeeding Marc Dunoyer upon the closing of its acquisition of Alexion Pharmaceuticals...
28 May 2021 18:48
(Sharecast News) - European shares pushed further into record territory on Friday with investors apparently brushing off data in the US showing quickening inflation.
28 May 2021 07:45
(Sharecast News) - AstraZeneca said its Tagrisso cancer drug had been approved in the European Union after positive results from a phase 3 trial.
25 May 2021 13:07
(Sharecast News) - Travis Perkins: Deutsche Bank resumes coverage with a recommendation to hold and a target price of 1,707p.
25 May 2021 12:35
(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA...
25 May 2021 08:24
(Sharecast News) - Britain's Competition and Markets Authority (CMA) said it is looking into AstraZeneca's $39bn acquisition of America's Alexion Pharmaceuticals over concerns the deal could...
21 May 2021 07:05
(Sharecast News) - AstraZeneca's Covid-19 vaccine has been granted a special approval for emergency use in Japan for people aged 18 years and older, the company said on Friday.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.